← FDA DRUG APPROVALS

FDA NDA · NDA018087

THYREL TRH

Sponsor: FERRING

APPLICATION
NDA018087
TYPE
NDA
ORIGINAL APPROVAL
1978-07-18
LATEST ACTION
1994-06-23
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

THYREL TRHDiscontinued
PROTIRELIN 0.5MG/ML · INJECTABLE · INJECTION

Approval history

1994-06-23Labeling · Supplement 13 · standardAP
1992-07-21Labeling · Supplement 12 · standardAP
1991-04-23Labeling · Supplement 11 · standardAP
1991-04-03Labeling · Supplement 10 · standardAP
1986-07-01Labeling · Supplement 8 · standardAP
1985-09-03Labeling · Supplement 7 · standardAP
1984-11-13Manufacturing (CMC) · Supplement 6 · standardAP
1983-07-28Manufacturing (CMC) · Supplement 4 · standardAP
1981-12-10Labeling · Supplement 5 · standardAP
1979-05-15Manufacturing (CMC) · Supplement 2 · standardAP
1978-07-18Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →